ABBOTT LABORATORIES — Capital/Financing Update 2017

Feb 21, 2017

8-K/A 1 a2230960z8-ka.htm 8-K/A QuickLinks -- Click here to rapidly navigate through this document

COMMAND=ADD_BASECOLOR,"#000000" COMMAND=ADD_DEFAULTFONT,"font-family:times;" COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;"

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

COMMAND=ADD_LINERULETXT,NOSHADE COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="CENTER" COMMAND=ADDING_LINEBREAK

FORM 8-K/A (Amendment No. 1)

CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

January 4, 2017 Date of Report (Date of earliest event reported)

ABBOTT LABORATORIES (Exact name of registrant as specified in charter)

COMMAND=ADD_LINERULETXT,NOSHADE COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="CENTER" COMMAND=ADDING_LINEBREAK

User-specified TAGGED TABLE

Illinois (State or other Jurisdiction of Incorporation) 1-2189 (Commission File Number) 36-0698440 (IRS Employer Identification No.)

end of user-specified TAGGED TABLE

COMMAND=ADD_LINERULETXT,NOSHADE COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="CENTER" COMMAND=ADDING_LINEBREAK

100 Abbott Park Road Abbott Park, Illinois 60064-6400 (Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: (224) 667-6100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

COMMAND=ADD_LINERULETXT,NOSHADE COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="CENTER" COMMAND=ADDING_LINEBREAK

BLANK LINE TO FORCE PARA

ZEQ.=1,SEQ=1,EFW="2230960",CP="ABBOTT LABORATORIES",DN="1",CHK=244867,FOLIO='blank',FILE='DISK124:[17ZAM1.17ZAM14701]BA14701A.;6',USER='ABEAULI',CD='17-FEB-2017;14:58' THIS IS THE END OF A COMPOSITION COMPONENT

COMMAND=ADD_BASECOLOR,"#000000" COMMAND=ADD_DEFAULTFONT,"font-family:times;" COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;"

TOC_END

This Amendment No. 1 on Form 8-K/A is being filed by Abbott Laboratories ("Abbott") to amend the Current Report on Form 8-K filed on January 5, 2017 (the "Original Report") to provide the disclosures required by Item 9.01 of Form 8-K that were previously omitted from the Original Report as permitted by Item 9.01(a)(4). Except as provided herein, the disclosures made in the Original Report remain unchanged.

Item 2.01. Completion of Acquisition or Disposition of Assets.

Pursuant to the terms and conditions of that certain Agreement and Plan of Merger, dated as of April 27, 2016, by and among Abbott, St. Jude Medical, Inc., Vault Merger Sub, Inc. and Vault Merger Sub, LLC, Abbott completed the acquisition of St. Jude Medical, Inc. (the "Transaction") on January 4, 2017.

In connection with the Transaction, Abbott filed the Original Report describing the acquisition. Abbott is now filing this amendment to include the historical financial statements and pro forma financial information required by Item 9.01 of Form 8-K.

Item 9.01 Financial Statements and Exhibits

(a) Financial Statements of Business Acquired

The audited St. Jude Medical, Inc. consolidated statements of earnings, statements of comprehensive income, statements of shareholders' equity and statements of cash flows for three-year period ended December 31, 2016, the audited St. Jude Medical, Inc. consolidated balance sheets as of December 31, 2016 and January 2, 2016, and the accompanying Notes to the Consolidated Financial Statements are attached hereto as Exhibit 99.1 and incorporated by reference.

(b) Pro forma financial information

The following information is attached hereto as Exhibit 99.2 and incorporated herein by reference:

(d) Exhibits

COMMAND=ADD_TABLEWIDTH,"100%" User-specified TAGGED TABLE

Exhibit No.	Exhibit
23.1	Consent of Ernst & Young LLP, independent registered public accounting firm for St. Jude Medical, Inc.
99.1	Audited Financial Statements of St. Jude Medical, Inc.
99.2	Pro Forma Financial Information.

end of user-specified TAGGED TABLE

1

ZEQ.=1,SEQ=2,EFW="2230960",CP="ABBOTT LABORATORIES",DN="1",CHK=613201,FOLIO='1',FILE='DISK124:[17ZAM1.17ZAM14701]DA14701A.;7',USER='CHE106465',CD='20-FEB-2017;10:51' THIS IS THE END OF A COMPOSITION COMPONENT

COMMAND=ADD_BASECOLOR,"#000000" COMMAND=ADD_DEFAULTFONT,"font-family:times;" COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;"

TOC_END

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

COMMAND=ADD_TABLEWIDTH,"100%" User-specified TAGGED TABLE

Date: February 21, 2017	ABBOTT LABORATORIES — By:	/s/ BRIAN B. YOOR Brian B. Yoor Executive Vice President, Finance and Chief Financial Officer

end of user-specified TAGGED TABLE

2

ZEQ.=1,SEQ=3,EFW="2230960",CP="ABBOTT LABORATORIES",DN="1",CHK=631708,FOLIO='2',FILE='DISK124:[17ZAM1.17ZAM14701]DC14701A.;7',USER='ABEAULI',CD='20-FEB-2017;19:00' THIS IS THE END OF A COMPOSITION COMPONENT

COMMAND=ADD_BASECOLOR,"#000000" COMMAND=ADD_DEFAULTFONT,"font-family:times;" COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;"

TOC_END

EXHIBIT INDEX

COMMAND=ADD_TABLEWIDTH,"100%" User-specified TAGGED TABLE

Exhibit No.	Exhibit
23.1	Consent of Ernst & Young LLP, independent registered public accounting firm for St. Jude Medical, Inc.
99.1	Audited Financial Statements of St. Jude Medical, Inc.
99.2	Pro Forma Financial Information.

end of user-specified TAGGED TABLE

3

ZEQ.=1,SEQ=4,EFW="2230960",CP="ABBOTT LABORATORIES",DN="1",CHK=317386,FOLIO='3',FILE='DISK124:[17ZAM1.17ZAM14701]DE14701A.;9',USER='ABEAULI',CD='17-FEB-2017;14:58' THIS IS THE END OF A COMPOSITION COMPONENT

QuickLinks

TOC_BEGIN

TOC_BEGIN SIGNATURE TOC_BEGIN EXHIBIT INDEX SEQ=,FILE='QUICKLINK',USER=JTAYLORA,SEQ=,EFW="2230960",CP="ABBOTT LABORATORIES",DN="1" TOCEXISTFLAG